Celgene Corp (CELG)

CELG (NASDAQ:Drugs) EQUITY
$131.25
pos +0.00
+0.00%
Today's Range: 130.77 - 133.00 | CELG Avg Daily Volume: 4,629,800
Last Update: 07/31/15 - 3:59 PM EDT
Volume: 0
YTD Performance: 17.33%
Open: $0.00
Previous Close: $131.88
52 Week Range: $83.16 - $140.72
Oustanding Shares: 790,540,158
Market Cap: 104,256,436,037
6-Month Chart
TheStreet Ratings Grade for CELG
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 11 12 12 13
Moderate Buy 1 1 1 1
Hold 3 3 3 3
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.47 1.44 1.44 1.41
Latest Dividend: 0.00
Latest Dividend Yield: 0.00%
Dividend Ex-Date: 12/31/69
Price Earnings Ratio: 49.95
Price Earnings Comparisons:
CELG Sector Avg. S&P 500
49.95 50.00 25.63
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
21.46% 50.60% 283.44%
GROWTH 12 Mo 3 Yr CAGR
Revenue 18.10 0.58 0.16
Net Income 37.90 0.52 0.15
EPS 42.00 0.72 0.20
Earnings for CELG:
EBITDA 2.94B
Revenue 7.67B
Average Earnings Estimates
Qtr (09/15) Qtr (12/15) FY (12/15) FY (12/16)
Average Estimate $1.01 $1.16 $4.22 $5.53
Number of Analysts 1 1 1 1
High Estimate $1.01 $1.16 $4.28 $5.53
Low Estimate $1.01 $1.16 $4.15 $5.53
Prior Year $0.88 $0.91 $3.36 $4.22
Growth Rate (Year over Year) 14.77% 27.47% 25.45% 31.20%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
Drugmaker has one of the best showings of earnings season.
Drugmaker has one of the best showings of earnings season.
Biogen's weak numbers leave biotechs ailing.
How Netflix, Tesla and Amazon Are helping this market grind higher.
The fearsome foursome have been reborn.

That Was the Week That Was Real Money Pro($)

Let's review.
They should learn to trust techs, financials.
It's like buying at the top -- and I don't like buying at the top.

Columnist Conversations

$51 billion - How much Uber is valued at in its last financing round. The unicorns keep growing. Back in the ...
....put protection is cheap! Seems every time we come down to this 12 or 11 level in VIX there is a whack, an...
Chevron (CVX) and the weak weekly chart, or is it?    Why would anyone want to buy a stock that is...
Care to comment on my prior post?

REAL MONEY'S BEST IDEAS

News Breaks

Powered by

Columnist Tweets

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.